Compound Detail
CHEMBL1134
DECAMETHONIUM BROMIDE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1134 |
| Name | DECAMETHONIUM BROMIDE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | HLXQFVXURMXRPU-UHFFFAOYSA-L |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1190 |
| Active Moiety | CHEMBL1190 |
3
Targets
12
Activities
2
Assay Types
0
PK Parameters
17
Publications
6
Known Names
1
Mechanisms
Molecular Properties
258.5
MW (Da)
3.52
ALogP
0
HBA
0
HBD
0.0
PSA (Ų)
0.39
QED
0
Ro5 Violations
11
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1982 |
| Availability | Discontinued |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Muscle-type nicotinic acetylcholine receptor partial agonist | PARTIAL AGONIST | Muscle-type nicotinic acetylcholine receptor | ✓ | ✓ |
Activity Summary
IC50 11 meas. best 6.4
Ki 1 meas. best 5.24
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Plasmodium falciparum CHEMBL364 | IC50 | 6.4 | 5.768 | 398.1 | 10 |
| Acetylcholinesterase CHEMBL220 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Neuronal acetylcholine receptor; alpha4/beta2 CHEMBL1907596 | Ki | 5.24 | 5.24 | 5730.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 7 |
| 16420066 | 10.1021/jm0508843 | RBCs | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 20382538 | 10.1016/j.bmc.2010.03.067 | Plasmodium falciparum | 2 |
| 20382538 | 10.1016/j.bmc.2010.03.067 | ADMET | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.1101/2020.04.03.023846 | SARS-CoV-2 | 1 |
| 24811300 | 10.1016/j.bmc.2014.04.019 | Acetylcholinesterase | 1 |
| 20020916 | 10.1080/15376510701857262 | Phospholipidosis | 1 |
| 17417631 | 10.1038/nchembio873 | Unchecked | 1 |
| 12372503 | 10.1016/s0960-894x(02)00687-x | Neuronal acetylcholine receptor; alpha4/beta2 | 1 |
| 16420066 | 10.1021/jm0508843 | Phospholipase B | 1 |
| 16420066 | 10.1021/jm0508843 | Candida albicans | 1 |
| 16420066 | 10.1021/jm0508843 | Cryptococcus neoformans | 1 |
| 9357523 | 10.1021/jm9701886 | Plasmodium falciparum | 1 |
| 12372503 | 10.1016/s0960-894x(02)00687-x | Neuronal acetylcholine receptor subunit alpha-7 | 1 |
Data from ChEMBL 36 via Core Engine